Document is current
Any future updates will be listed below
-
Authors
Reitsam, Nic G. https://orcid.org/0000-0002-0070-3158
Grosser, Bianca
Steiner, David F. https://orcid.org/0000-0003-1297-0023
Grozdanov, Veselin
Wulczyn, Ellery
L’Imperio, Vincenzo https://orcid.org/0000-0002-9284-2998
Plass, Markus https://orcid.org/0000-0003-2718-7648
Müller, Heimo https://orcid.org/0000-0002-9691-4872
Zatloukal, Kurt https://orcid.org/0000-0001-5299-7218
Muti, Hannah S.
Kather, Jakob N. https://orcid.org/0000-0002-3730-5348
Märkl, Bruno https://orcid.org/0000-0002-7704-850X
- License Information
-
More Information
Article History
Received: 7 December 2023
Accepted: 5 August 2024
First Online: 15 August 2024
Competing interests
: J.N.K. declares consulting services for Owkin, France, DoMore Diagnostics, Norway, Panakeia, UK, Scailyte, Switzerland, Mindpeak, Germany, and Histofy, UK; furthermore, he holds shares in StratifAI GmbH, Germany, and has received honoraria for lectures by AstraZeneca, Bayer, Eisai, MSD, BMS, Roche, Pfizer and Fresenius; all of these are not related to this study. B.M. has received compensation for travel expenses and fees for advisory board activities by AstraZeneca, Boehringer Ingelheim, Merck, MSD, BMS, Bayer, and Novartis, not related to this study. K.Z. is founder and CEO of Zatloukal Innovations GmbH. D.F.S. and E.W. are current or past employees of Google LLC and own Alphabet stock.
